Log In
BCIQ
Print this Print this
 

Mulpleta, lusutrombopag (S-888711)

  Manage Alerts
Collapse Summary General Information
Company Shionogi & Co. Ltd.
DescriptionOral small molecule thrombopoietin (TPO) receptor (CD110; Mpl) agonist
Molecular Target Thrombopoietin (TPO) receptor (CD110) (Mpl)
Mechanism of ActionThrombopoietin (TPO) receptor (CD110) (Mpl) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationThrombocytopenia
Indication DetailsTreat thrombocytopenia; Treat thrombocytopenia associated with chronic liver disease in patients prior to elective invasive procedures
Regulatory Designation Japan - Standard Review (Treat thrombocytopenia)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today